Survival and Safety Outcomes of Avelumab Maintenance Therapy for Advanced Urothelial Carcinoma from a Single-Center Experience
Avelumab maintenance therapy demonstrated favorable survival outcomes and tolerability in patients with advanced UC in daily practice.
Authors
- Takuo Matsukawa (ORCID: https://orcid.org/0009-0009-4418-399X)
- Naohiro Fujimoto (ORCID: https://orcid.org/0000-0002-5256-6415)
- Eiji Kashiwagi (ORCID: https://orcid.org/0000-0001-9424-3764)
- Yui Mizushima
- Ikko Tomisaki (ORCID: https://orcid.org/0000-0002-7818-0780)
- Akinori Minato (ORCID: https://orcid.org/0000-0001-6303-1128)
- Rieko Kimuro
- Yujiro Nagata
- Yoshihiro Sugita
- K. Jojima
- T Takaba
- Katsuyoshi Higashijima
Institutions
- University of Occupational and Environmental Health Japan (JP)
Publication Details
- Journal
- In Vivo
- Published
- 2025-06-27
- DOI
- https://doi.org/10.21873/invivo.14008
- Primary Topic
- Bladder and Urothelial Cancer Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- University of Occupational and Environmental Health